Top Vaccines companies in Japan by Net Cash Used Provided By Financing Activities

This ranking features the top 15 Vaccines companies in Japan ranked by Net Cash Used Provided By Financing Activities, totaling a Net Cash Used Provided By Financing Activities of USD 2.92 B, for February 08, 2025.
#
Name
Net Cash Used Provided By Financing Activities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 4.06 B
March 31, 2024 USD 9.46 1.16%

Japan

2
USD 8.10 M
Dec. 31, 2023 USD 3.66 1.69%

Japan

3
USD 5.62 M
Dec. 31, 2023 USD 2.65 4.67%

Japan

4
USD 4.82 M
Dec. 31, 2023 USD 1.21 0.22%

Japan

5
USD 4.57 M
March 31, 2024 USD 0.28 0.77%

Japan

6
USD 4.44 M
March 31, 2024 USD 0.17 4.80%

Japan

7
USD 1.87 M
Dec. 31, 2023 USD 13.30 2.22%

Japan

8
USD 24.63 K
March 31, 2024 USD 0.93 0.77%

Japan

9
USD -1.62 M
June 30, 2024 USD 1.00 0.77%

Japan

10
USD -8.21 M
March 31, 2024 USD 11.55 2.65%

Japan

11
USD -13.42 M
March 31, 2024 USD 3.30 4.32%

Japan

12
USD -16.87 M
Dec. 31, 2023 USD 9.92 1.44%

Japan

13
USD -66.11 M
March 31, 2024 USD 24.56 1.18%

Japan

14
USD -224.84 M
March 31, 2024 USD 9.63 -2.79%

Japan

15
USD -838.12 M
March 31, 2024 USD 14.57 3.59%

Japan

Frequently Asked Questions
  • Which Vaccines company in Japan has the highest Net Cash Used Provided By Financing Activities ?

    The Vaccines company in Japan with the highest Net Cash Used Provided By Financing Activities is Astellas Pharma Inc. (Tokyo Stock Exchange: 4503.T) at USD 4.06 B.

  • Which Vaccines company in Japan has the lowest Net Cash Used Provided By Financing Activities ?

    The Vaccines company in Japan with the lowest Net Cash Used Provided By Financing Activities is Shionogi & Co., Ltd. (Tokyo Stock Exchange: 4507.T) at USD -838.12 M.

SV Wall Street